Apologies if it has already been asked or commented on (I couldn't make the call and am quickly scrolling through the threads), but was there any mention of Phase 3 trial for NNZ-2591 and the Type C meeting with the FDA.
One positive I am taking from the comments above is that they would partner at this stage ONLY if it was a knock out offer, so they must be pretty confident this meeting will go well.
Apologies if it has already been asked or commented on (I...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.18 |
Change
0.870(6.54%) |
Mkt cap ! $1.758B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $8.058M | 581.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 457 | $14.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.32 | 269 | 2 |
View Market Depth
| Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |